Simulations Plus Releases GastroPlus® Version 9.8.1
Simulations Plus, Inc. (SLP)
Last simulations plus, inc. earnings: 4/9 04:35 pm
Check Earnings Report
US:NASDAQ Investor Relations:
simulations-plus.com/software/overview
Company Research
Source: Business Wire
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it has released version 9.8.1 of its flagship physiologically based biopharmaceutics (PBBM) / pharmacokinetics (PBPK) modeling program, GastroPlus®. For over 20 years, Simulations Plus has been dedicated to improving state-of-the-art software tools, educating scientists worldwide with the best and most innovative science, and advancing in silico modeling and simulation.Key improvements in this version include:More mechanisms, verification, and guidance for our validated drug-drug interaction (DDI) modelsA “Validated” column in the DDI perpetrator table to clearly identify the values that have been validated by our DDI experts for use in simulationsA new option to include variability in lung deposition in the Population SimulatorNew enhancements when impo
Show less
Read more
Impact Snapshot
Event Time:
SLP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SLP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SLP alerts
High impacting Simulations Plus, Inc. news events
Weekly update
A roundup of the hottest topics
SLP
News
- InnoGI Technologies and Simulations Plus Combine Forces to Offer Next-Level Modeling Solutions for the Prediction of Oral Drug Performance [Yahoo! Finance]Yahoo! Finance
- Simulations Plus (SLP) DILIsym Software Licenses Renewed by FDA [Yahoo! Finance]Yahoo! Finance
- Earnings Update: Simulations Plus, Inc. Beat Earnings And Now Analysts Have New Forecasts For This Year [Yahoo! Finance]Yahoo! Finance
- Simulations Plus stock jumps 25% amid FDA renewal, earnings report [Seeking Alpha]Seeking Alpha
- Simulations Plus, Inc. (NASDAQ:SLP) Q2 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
SLP
Earnings
- 4/3/24 - Beat
SLP
Sec Filings
- 4/5/24 - Form 10-Q
- 4/3/24 - Form 8-K
- 4/2/24 - Form 4
- SLP's page on the SEC website